FPAS
EW icon

Focus Partners Advisor Solutions’s Edwards Lifesciences EW Stock Holding History

Focus Partners Advisor Solutions’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,093
Closed -$1.05M – 1301
2026
Q1 		$1.05M Sell
13,093
-1,380
-10% -$114K 0.01% 543
2025
Q4 		$1.23M Buy
14,473
+73
+0.5% +$5.99K 0.02% 438
2025
Q3 		$1.17M Buy
14,400
+5,512
+62% +$431K 0.01% 472
2025
Q2 		$695K Buy
8,888
+1,499
+20% +$112K 0.01% 560
2025
Q1 		$535K Buy
7,389
+3,195
+76% +$229K 0.01% 570
2024
Q4 		$310K Sell
4,194
-3,979
-49% -$278K 0.01% 597
2024
Q3 		$539K Sell
8,173
-1,682
-17% -$122K 0.01% 435
2024
Q2 		$910K Buy
+9,855
New +$873K 0.02% 261

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Focus Partners Advisor Solutions's EW Position: Q2 2026 in Review

Focus Partners Advisor Solutions sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 13,093 shares — an estimated $1.05M sold.

Focus Partners Advisor Solutions first reported a position in EW in Q2 2024 and held it in 8 quarters. The position peaked at $1.23M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Focus Partners Advisor Solutions reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 13,093 Edwards Lifesciences shares in Q2 2026, an estimated $1.05M.
  • Focus Partners Advisor Solutions first reported a position in Edwards Lifesciences in Q2 2024 and held it in 8 quarters.
  • Focus Partners Advisor Solutions's Edwards Lifesciences position peaked at $1.23M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.